Surgery for spontaneous intracerebral hemorrhage - A comparative study with medical management in moderate to large

Ajay Hegde1, Girish Menon2, Vinod Kumar2

  • 1Department of Neurosurgery, Kasturba Medical College, Manipal Academy of Higher education, Manipal, India; Institute of Neurological Sciences, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United kingdom.

Insights

Surgical evacuation of intracerebral hemorrhage (ICH) in patients under 70 with large clots improves survival rates at 90 days. While functional outcomes were similar, surgery significantly reduced mortality compared to conservative management.

Area of Science:

  • Neurosurgery
  • Neurology
  • Stroke Medicine

Background:

  • Intracerebral Hemorrhage (ICH) is a severe stroke type with high mortality.
  • Current management primarily relies on conservative approaches, with surgical evacuation showing limited proven benefits in past trials.
  • Selected patients may benefit from surgical intervention to reduce mortality and disability.

Purpose of the Study:

  • To compare the outcomes of surgical versus conservative management for Intracerebral Hemorrhage (ICH).
  • To analyze the impact of surgical evacuation on mortality and functional outcomes in specific patient cohorts.
  • To evaluate the efficacy of surgical intervention in patients under 70 with large supratentorial hematomas.

Main Methods:

  • Retrospective analysis of 119 patients with supratentorial hematoma volume >30 ml, GCS ≥ 5, and age < 70.
  • Patients were divided into two groups: surgical intervention (Group A, n=72) and conservative management (Group B, n=47).
  • Outcomes including 90-day mortality and functional status (mRS) were compared between groups.

Main Results:

  • The surgical group had a significantly lower 90-day mortality rate (31.9%) compared to the conservative group (57.44%).
  • Hematoma volume was larger in the surgical group (46.5 ml) versus the conservative group (38.53 ml).
  • While mortality was reduced by surgery, median modified Rankin Scale (mRS) scores at discharge and 90 days were similar between groups.

Conclusions:

  • Surgical evacuation of spontaneous intracerebral hemorrhage in moderate to large hematomas offers a survival advantage at 90 days.
  • Surgery did not demonstrate a significant improvement in functional outcomes (mRS) compared to conservative management.
  • Surgical intervention may reduce mortality associated with delayed perihematomal edema in moderate-sized hematomas.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
217
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
182
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
321
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
253
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
406